Brevan Howard Capital Management »

Protagonist Therapeutics shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $505k 7.6k 66.43
2025-06-30 $1.5M 27k 55.27
2025-03-31 $779k 16k 48.36
2024-06-30 $311k 9.0k 34.65
2023-12-31 $271k 12k 22.93

More positions owned by Brevan Howard Capital Management

Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Pdd Holdings Sponsored Ads Call Option (PDD)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Dbx Etf Tr Xtrack Hrvst Csi Call Option (ASHR)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Coinbase Global Com Cl A Call Option (COIN)
Baidu Spon Adr Rep A Call Option (BIDU)
Agnico Call Option (AEM)
Alphabet Cap Stk Cl A Put Option (GOOGL)

View all positions for Brevan Howard Capital Management

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Vanguard Group
Rtw Investments
State Street Corporation
UBS Group
BVF
Johnson & Johnson
Wellington Management Company
Invesco
Geode Capital Management
Woodline Partners
Driehaus Capital Management
Henderson Group
ADAR1 Capital Management

View all funds holding Protagonist Therapeutics